CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 171 enrolled
Drug / intervention
Potassium Bicarbonate +3 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00357214
NCT00357214N/ACompleted

Effect of Potassium Bicarbonate on Bone and Muscle

Tufts University·interventional·Posted Jul 27, 2006·Updated Feb 17, 2020

In Brief

A clinical study evaluating Potassium Bicarbonate, Sodium Bicarbonate, and 2 other interventions for Osteoporosis and Sarcopenia. Completed, enrolled 171 participants across 1 site.

Detailed Summary

There is increasing evidence that the acid-base balance of diet plays an important role in the health of bones and muscles. An excess of acid in the body can result in calcium loss and muscle breakdown. Potassium bicarbonate, a base supplement, can neutralize acid within the body. The purpose of this study is to determine the effectiveness of potassium and bicarbonate, alone and combined, at reducing bone loss and preventing muscle wasting in older adults.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 27, 2006
Enrollment StartSep 1, 2006
Primary CompletionApr 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 19.9 years ago

Interventions

Potassium Bicarbonatedietary

67.5 mmol/d given as three tablets after each meal, with a full glass of water

Sodium Bicarbonatedietary

67.5 mmol/d given as three tablets after each meal, with a full glass of water

Potassium Chloridedietary

67.5 mmol/d given as three tablets after each meal, with a full glass of water

placebo (microcrystalline cellulose)dietary

Given as three tablets after each meal, with a full glass of water